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RESUME 
INTRODUCTION Comprendre les déterminants de l'arrêt du tabagisme est un enjeu crucial, tant sur 
le plan clinique qu'en termes de santé publique. Dans l'étude transversale présentée ici, nous 
décrivons ce processus au travers de l'expérience d'ex-fumeurs. 
METHODE Sur une période de 4 mois, nous avons proposé à chaque patient consultant la 
Policlinique Médicale Universitaire de Lausanne de participer à une étude visant à examiner leur 
expérience de l'arrêt du tabagisme. Les critères d'inclusion étaient les suivants: (1) âge ~ 18 ans (2) 
connaissance minimale de la langue française (capacité de comprendre et répondre aux questions) (3) 
être un ex-fumeur (défini comme une personne actuellement abstinente mais ayant fumé au moins 100 
cigarettes [~ 5 paquets] pendant> 6 mois dans le passé). Une infirmière forll:ée a mené des entretiens 
semi-structurés en face-à-face avec les ex-fumeurs recrutés en utilisant un questionnaire explorant les 
67 questions parmi les thèmes suivants : caractéristiques démographiques et socioéconomiques ; 
habitudes antérieures de consommation; stades de motivation; influence de l'environnement social; 
état de santé et préoccupations au sujet de la santé ; perception des risques et des bénéfices du 
tabagisme ; perception de la dépendance nicotinique ; offre d'un counseling médical spécifique; 
connaissances sur les modalités thérapeutiques disponibles et méthodes utilisées pour arrêter de fumer. 
Les résultats sont exprimés en nombres absolus, en pourcentages, en moyennes et en dispersion. 
RESULTATS 88 ex-fumeurs ont été inclus dans l'étude. Leurs caractéristiques démographiques et 
socioéconomiques sont les suivantes : La grande majorité d'entre eux sont des hommes (81 %), l'âge 
moyen de 51 ans (variant de 19 à 81 ans), la moitié sont mariés, 72% de nationalité suisse et une 
grosse minorité ( 40%) ont une formation supérieure (universitaire ou équivalente). Leur histoire de 
consommation montre que l'âge moyen d'initiation du tabagisme est de 18 ans (entre 11 et 30 ans), et 
23% ont commencé avant 16 ans. La consommation moyenne était de 26 cigarettes/jour. Presque tous 
les sujets (92%) étaient en contact fréquent avec des fumeurs à la maison, à l'école, au travail ou avec 
des amis au moment où ils ont commencé à fumer. La moitié des patients a essayé à une ou deux 
reprises d'arrêter de fumer avant de parvenir à une réelle abstinence. La durée depuis leur arrêt de 
consommation de cigarettes était en moyenne· 5 ans et seuls 16% des sujets ont fumé 
occasionnellement depuis l'arrêt de leur consommation régulière. La majorité des ex-fumeurs (93%) 
dit avoir arrêté de manière abrupte et sans aucune aide thérapeutique (83%). 70 % des patients 
décrivent l'arrêt comme plutôt ou très difficile. Les problèmes décrits après l'interruption du 
tabagisme sont une prise pondérale (27%), la dépendance (23%), l'irritabilité (15%), les contacts avec 
des fumeurs (15%) et le manque de cigarette après les repas (11 % ). Les motivations principales à 
arrêter de fumer étaient des préoccupations générales au sujet de la santé (39%), des symptômes (23%) 
ou des signes cliniques spécifiques (22%), comme des problèmes cardiovasculaires ou resp'iratoires, 
ainsi que la conviction que le moment était venu d'arrêter (13%). D'autres motivations (comme les 
enfants, la grossesse, le coût...) étaient rarement mentionnées alors que 45% d'entre eux ont tout de 
même ressenti une pression de l'entourage, principalement -de la part de personnes vivant sous le 
même toit, de leurs famille ou amis. L'effet positif majeur de l'abstinence' est, à leurs yeux, une 
amélioration globale de la santé (48%) ou de leurs problèmes cardiovasculaires ou respiratoires (32%). 
Trois quarts (74 %) des sujets savent que les cigarettes dites « légères» sont aussi nuisibles que les 
cigarettes normales, et 90 % sont conscients du fait que la nicotine peut induire une dépendance ; la 
moitié d'entre eux ne réalisent toutefois pas que le filtre ne protège pas contre les dangers de 
l'inhalation de fumée. Près de trois quarts (73%) des ex-fumeurs disent avoir été interrogés sur leur 
consommation de tabac à l'occasion d'une consultation médicale motivée par un problème de santé et 
30% clairement encouragés à arrêter par leur médecin. A ce sujet, 78 % sont d'avis qu'un médecin 
devrait par principe conseiller un arrêt du tabac. 
CONCLUSION Les 88 ex-fumeurs de cet échantillon ont, pour la plupart, arrêté la cigarette par leurs 
propres moyens, après un ou plusieurs échecs. Leurs motivations principales étaient le souci de leur 
propre santé, globalement ou relativement à des symptômes ou des signes cliniques spécifiques, ce qui 
reflète le fait que les patients sont relativement bien informés des dangers liés à_ la consommation de 
tabac. Enfin, le fumeur. est sensible à l'influence de son environnement social, et, dans cette 
perspective, l'abstinence devrait être encouragée par les autorités sanitaires, les professionnels de la 
santé et les autres membres de la communauté. 
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1. INTRODUCTION 
1.1 THE TOBACCO EPIDEMIC 
Tobacco is known to be one of the major successes of epidemiology yet at the same time the 
most obvious failure of disease prevention. Despite much evidence of their health hazards, 
tobacco products are still heavily consumed in the industrialized world as well as in the 
developping countries. Smoking remains the main preventable cause of early morbidity and 
mortality in Europe, North America and Australia. As a consequence of its high prevalence in 
the general population and its pathogenic role in the developpement of multiple disease 
processes, tobacco control is currently considered as a major public health issue at the dawn of 
the 21st century. Globally, the increase in the frequency of tobacco-related disease and 
casualties has demonstrated epidemic features for the last few decades. The recent estimates 
of global tobacco-associated mortality -over 3 millions deaths/year- draws an evocative 
picture of the current impact ofthis risk behavior (1). 
In Switzerland, there are around 1. 7 million active smokers for about 7 million people, an 
approximate prevalence of 30% (2). These are not evenly distributed throughout all age 
groups; there is a clear clustering among youth and young adults: 31 to 44% of the young 
adult Swiss population currently smokes. The proportion of female smokers has beert 
progressively « catching up » with that among men since the 70's. The proportion of heavy 
smokers (> 20 cig/d) is higher in men than among woman and culminates between the ages 
from 25 to 44 years (2,3). 
We can estimate that each year 60 to 100'000 Swiss, recruited primarily during adolescence, 
become regular smokers. According to a WHO 1996 statement, the median age of initiation 
to tobacco use is inferior to 15 years in many countries (4). Old smokers who quit, often for 
personal health problems, are being constantly replaced by young initiates who thus perpetuate 
the public health burden of tobacco-related disease. In this respect, smoking can also be 
considered a pediatric and adolescent health issue. Before exploring the putative reasons for 
initiation and maintenance of this risk behavior, the medical consequences of cigarette 
smoking are reviewed. 
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1.2 RISKS OF SMOI<ING 
The three maJor tobacco-related diseases are cancer, cardiovacular disease and chronic 
respiratory disease. 
The smoker is tepeatedly exposed to vanous orgamc compounds (polynuclear aromatic 
hydrocarbons and the nicotine-derived nitrosamines) present in tobacco smoke. These actas 
powerful carcinogenic or genotoxic agents by forming DNA adducts, which cause permanent 
mutations in critical genes. As a consequence, a smoker has a higher risk than non-smoker of 
dying from lung cancer (relative risk 6.5 to 26.9), depending on level of exposure (6,7,9). In 
addition to bronchogenic carcinoma, tobacco users are also at increased risk of oral, 
pharyngeal, laryngeal, oesophagal, bladder and pancreatic cancer. 
Tobacco smoke is an established maJor risk factor for the developpement of arterial 
atheromatous plaques, presumably due to the exertion of direct oxydative damage to the 
arterial wall and by the effect of carbon monoxide on tissue hypoxia. The relative risk of 
cardiovascular death is 1.9 to 2.0 for smokers as compared with non smokers (7,8,10). 
The irritant properties of inhaled smoke induce a chronic inflammation of respiratory mucosal 
membranes, manifested by a chronic bronchitis. They also accelerate ventilatory fonction 
decline associated with normal aging and thus lead to emphysema by progressive and dose-
dependant irreversible peripheral alveolar damage. The relative risk for chronic obstructive 
lung disease in smokers is 6 times that of abstainers (10). These chronic obstructive 
pulmonary diseases lead to respiratory failure, a major permanently disabling outcome. 
Many cohort studies have demonstrated an increase in the all-cause mortality rates of both 
genders. Half of all smokers die prematurely from tobacco-related disease (5). The American 
Cancer Society survival studies ÀCS I (1966) and II (1990) showed, for example, that the 
relative risk of premature death ranges between 1.6 and 2.2 for those at a low exposure level 
(1-20 cig/d) and between 1.9 and 2.4 for those at a higher exposure level (~ 20 cig/d (6,7). In 
Switzerland, the death toll attributable to tobacco products consumption is about 10'000 
deaths/year (i.e. 12-17% of overall mortality), more than twice the 1976 figures. Tobacco is 
responsible for a loss of 100'000 to 120'000 years of healthy life (8,9). 
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1.3 BENEFITS OF SMOKING CESSATION 
The tobacco-related morbidity and mortality risks are reversible after smoking céssation. 
Several studies have consistently demonstrated a decline in overall and specific mortality rates 
after quitting. According to the ACS I and II, the general mortality risk for low level exposure 
smokers decrease gradually after cessation to normal (1.0) after 10 years. For high level 
exposure, the risk decreases in a similar fashion but stabilizes at a slightly higher value (1.2) 
after 15 years. The same trend in risk decline is observed notably for cardiovascular disease 
and more slowly for cancer mortality (6,7). As for chronic pulmonary disease, the reduction in 
pulmonary function parallels that of non-smoker controls a few years after successful quitting 
(10,11). All these elements illustrate the crucial importance attributed to smoking cessation. 
Unfortunately, the spontaneous quit rate for tobacco is remarkably low: 2 to 4% per year. 
Providing information about the noxious consequences of smoking to the regular consumer is 
insufficient to help the smoker end his risk behavior. Since the 80's, .medical research has 
shown the strong addictive potential of tobacco. 
1.4 NICOTINE DEPENDENCE 
Psychobiologie effects of nicotine 
Nicotine is a water- and lipid-soluble base which is readily absorbed through oral mucosal 
membranes and pulmonary alveoli after inhalation, chewing or snuffirtg. It is then rapidly 
distributed from the bloodstream to various peripheral and central neural binding sites. Its 
actions on the peripheric nervous system include changes in skeletal muscle tension, 
stimulation of intestinal peristaltism, increased heart rate and modulation of the pituitary-
, 
adrenal hormonal axis. In the central nervous system, the subtle and diverse psychoactive 
effects of nicotine seem to be related to its simultaneous direct or indirect influence on the 
activity of several neuronal systems (12). 
The instantaneous surge of bloodstream nicotine after each cigarette is associated with a 
variety of psychoactive effects showing a great inter- and intra-individual variability mainly 
depending on the psychosocial context and the time span since the last cigarette (13). The 
most frequently reported beneficial manifestations are sensory pleasure, cognitive arousal, 
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affect modulation (anxiolytic/antidepressive effect, stress control), hunger and weight control 
and facilitation of social contacts. 
Nicotine is now widely recognized as an addictive chemical because of its numerous 
psychotropic effects and its capacity to induce a state of dependency. This state can be 
identified in the consumption pattern of most of the regular smokers, fitting both the DSM-IV 
and IDC-10 diagnostic criteria (appendices 1-2). This multifaceted dependence can be 
described in 3 distinct levels which illustrate nicotine's propensity to gradually penetrate 
diffetent personality layers and become anchored in the intimate core of the individual by 
reinforcing the factors involved in the drive to compulsive use. These three levels can be 
described as following: 1. Psychological dependence: the smoker. needs to repeatedly 
experience the psychoactive effect of nicotine (positive reinforcement). 2. Physical 
dependence: the smoker actively avoids the displeasing effects of nicotine deprivation 
(negative reinforcement). 3. Behavioral dependence: habit plays an important role in 
maintaining cigarette smoking. Because of its social acceptance and the high frequency of its 
daily use, tobacco smoking can be coupled with a great variety of professional and 
recreational activities. With time, the strengthening of these associations leads to automatic 
smoking as a conditioned response to a wide variety of internai and environmental stimuli. 
It must be outlined that nicotine dependence is not a dichotomous outcome, either present or 
absent. Rather, it can be described as a dynamic process that evolves over time as a fonction 
of progressive biological tolerance and deeper integration of the smoking habit in the 
behavioral patterns of the consumer. As there are no biologie markers of tobacco addiction, 
several questionnaires have been developed to assess nicotine dependence. The most widely 
used is the Fagerstrom Test for Nicotine Dependence (FTND displayed in appendix 3), which 
provides the clinician with a score assumed to be representative of the severity of the 
addiction. 
The addictive nature of tobacco is also supported by the occurrence of a typical abstinence 
syndrome, which appears after a few hours of nicotine deprivation. This withdrawal effect 
poses the motivated quitter an often overwhelming challenge (13). The abstinence symptoms 
start within few hours (2 - 24 hours ), reach a climax from 24 to 48 hours, then gradually 
decrease to an end after 10 to 20 days of smoking cessation. The symptomatology is diverse 
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and may include a mix of the following complaints: general malaise (nausea, restlessness, 
tremor), cognitive depression (concentration, memory and task performance impairment), 
negative affect (anxiety, depressive or dysphorie mood, stress, insomnia, irritability, 
nervousness ), cigarette craving (irresistible need to smoke ), compulsive alimentary behavior 
(weight gain) and constipation. This syndrome may cause a significant distress or impairment 
in occupational, social or recreational functioning or an overt depressive disorder, which may 
preclude any quit attempt in a demanding and competitive modern society. The severity of the 
withdrawal symptoms combined with the cultural tolerance and the apparent short-term 
innocuity of cigarette smoking presumably accounts for the low spontaneous quit rate. 
1.5 SMOIZING CESSATION PROCESS 
Smoking cessation is not merely a rational abandonment of an old and harmful habit but a 
critical life experience which engenders a fundamental change in daily activities and a long-
lasting struggle for maintenance. One of the prerequisites of a cessation att(;)mpt is an 
awareness of the harmful nature of smoking and a firm motivation to change. When asked 
whether they envision a possible future cessation, about two-thirds of regular smokers want to 
quit in a more or less defined interval. One-third of regular smokers make a concrete attempt 
each year. In Switzerland, 600'000 tobacco users try to quit each year and about 100'000 
actually succeed, a little more than 5.5% of the total smoker population (14). 
Since the 1980's, some groups have focused on understanding the dependent smoker's 
personality and the mechanisms underlying the process of behavioral change which determine 
the transition to and maintenance of abstinence. 
The stages of change mode/ 
The first determinant of the probability of successful change is the motivational status of the 
potential quitter. To evaluate this variable for clinical research and therapy, Prochaska and 
Goldstein proposed a categorial scale model, which is currently the most widely used in 
international medical , litterature and clinical practice. They defined a continuum of 5 
successive stages correlated to the timing of a planned quit attempt (15). Each category is 
affiliated with its own specific pronostic. 
Table 1. Stages of change model: definitions and related prognosis 
Stage 
1. Precontemplation 
2. Contemplation 
3. Preparation 
4. Action 
5. Maintenance 
Definition 
quit > 6 months 
quit ~ 6 months 
quit ~ 1 month 
active cessation 
abstinence consolidation 
Probability abstinence at 6 months 
5% 
10% 
14% 
variable (upon intervention) 
variable (upon intervention) 
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This model describes smoking cessation as a dynamic process in which the so-called « happy 
smoker » (precontemplator) who enjoys his tobacco consumption becomes increasingly 
concerned by the harmful health impact of smoking ( contemplator). He eventually adopts an 
adaptative strategy (preparation), which allows him to actively modify his behavioral pattern 
(action) and maintain this change (maintenance). Very often, the action phase is followed by a 
relapse, which brings the smoker back to the contemplation stage. He thereby will repete the 
same course again in a cyclic or spiral trajectory. Definitive termination of the risk behavior 
will occur after one or several unsuccessful attempts. 
Apart from this model, data is scant and much uncertainty remams concermng other 
determinants of quitting. We currently lack a comprehensive description of the quitting 
process, whkh could allow us to define a set of pronostic variables. Many authors have 
analyzed interesting predictive variables, however, it is difficult' to draw a conclusive picture 
from this crude material. In contrast, treatment modalities have been thoroughly reviewed in 
several metaanalytic papers (16,17,18,19,20). Furthermore, studies on the quitting process 
have been performed in specialized populations. We used data on swiss smokers, especially 
on those attending an ambulatory care clinic. 
In the present cross-sectional survey, we aim to better understand the smoking cessation 
process through the profile of successful quitters. The effect of demographic and 
socioeconomic characteristics as well as smoking behavior variables (subjective benefits from 
tobacco use, perception of risks related to smoking, contact with other smokers, variation in 
social support, previous medical counseling) will be included in the analysis. The present 
study has also been designed to evaluate exsmokers' knowledge of nicotine dependence and · 
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available treatment, as well as patients' opm10ns on previous medical care and tobacco 
counseling. 
2. POPULATION AND METHODS 
The survey was carried out during a 4-month period. Each consecutive patient consulting at 
the Lausanne University Outpatient Clinic (a primary care and interna! medicine referral 
center) was asked to participate to a study to address tobacco smoke, irrespective of the reason 
for the consultation. The inclusion criteria were: 1) age~ 18 years 2) basic French language 
knowledge (ability to understand and answer the survey questions) 3) former smoker (defined 
as not currently smoking but has previously smoked at least 1 OO cigarettes i.e. ~ 5 packs for > 
6 months). The number of patients asked to participate was 1579, of whom 223 refused to 
participate, 780 did not meet the criteria for.a prior tobacco dependence (at least 100 cigarettes 
for more than 6 months ), 284 did not have a sufficient understanding of French, and 204 were 
current regular smokers. After excluding these patients, 88 (5.5%) patients were retained in 
the study. 
A German questionnaire was previously developed for a telephone survey of the general 
Swiss population by the Bern University lnstitute of Social and Preventive Medicine for the 
Swiss Federal Office for Public Health. A trained nurse conducted semi-structured interviews 
with the Lausanne patients using a French translation of this questionnaire, which was adapted 
for face-to-face interviews. The French version used in this study was pilot-tested on 20 
persons from the general population. The interview lasted about 15 to 20 minutes. The 
questionnaire included 67 questions exploring demographic and economic characteritics, 
consumption habits, motivational stage, influences from the social environment, health status 
and concerns, perception of risks and benefits of smoking, perception of nicotine dependenc;e, 
previous medical counseling, knowledge about smoking cessation treatments and methods of 
past quit attempts. The results are descriptive and expressed in counts, percentages, means 
and ranges. 
3. RESULTS , 
Eighty-eight consecutive former smokers were interviewed. Demographic and socioeconomic 
10 
characteristics are displayed in Table 2. The vast rnajority were men (81 %). The rnean age 
. was 51 years (range 19 to 81) and half (54 %) were rnarried. Seventy-two percent were of 
Swiss nationality, 18 % were immigrants frorn European countries and 10 % were non-
European immigrants. Half (49 %) were full-tirne workers. A rninority (40 %) had obtained a 
high education ( equivalent to a college or university degree ). Two-thirds had an average 
household incarne exceeding 4000 SFr. per rnonth. 
Data on former tobacco consurnption are also displayed in Table 2. The rnean age of smoking 
initiation was 18 years (range 11 to 30); 23 % started before age 16. Average daily cigarette 
consurnption ranged frorn 2 to 60 cigarette/day (rnean 26 cigarette/day). Alrnost all (92%) 
were in frequent contact with srnokers at home, at school, or at work place. The cessation data 
are displayed in Table 3. The rnajority reported they stopped abruptly (93 %) and without any 
kind of therapeutic help (83 %). Seventy percent of patients described the cessation process 
as rather or very difficult. The problerns the former srnokers had to cope with after quitting 
were weight gain (27%), dependence (23%), irritability (15 %), contact with active srnokers 
(15 %) and lack of cigarette after rneals (11 %). A quarter asked for sorne social support 
(rnainly farnily, friends or collegues). Avery srnall rninority (< 2%) reported receving rnedical 
support and use of nicotine substitution. The duration of smoking cessation ranges frorn 21 
days to 42 years with a rnean of approxirnately 5 years. Only 16 % of patients had srnoked 
occasionally since quitting (at least once in a week). 
An assessrnent of the former perception of smoking and motivation to quit revealed that the 
major negative aspects of smoking related to the decision to stop were : threat to general 
health (55 %), risk of pulrnonary diseases (22 %), nicotine addiction (19 %), nuisance to 
others (14 %) and indoor air pollution (13 %). (See Table 3.) The rnost frequently cited 
motivations to quit were: general concern about health (39 %), specific syrnptorns (23 %) or 
clinical signs (22 %), such as cardiovascular or respiratory problerns and the feeling that it 
was the right tirne to quit (13%). Other motivations (e.g., children, pregnancy, econornic 
burden) were not rnentioned frequently. To quantify social pressure to quit, the subjects were 
asked if they had been blarned for smoking: 45 % had endured sorne reproach, rnainly frorn 
household rnernbers, parents or friends. 
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The patients frequently mentioned the following positive effects of smoking cessation: 
improvement of global health (48 %) and of respiratory or cardiovascular symptoms (32 %). 
As far as their knowledge on smoking and health, 74 % of patients knew that low-nicotine 
content ("light") cigarettes are as deleterious to health as regular cigarettes, and 90 % believed 
that nicotine can be addictive. However, half of them were not aware that the filter does not 
protect the smoker against the dangers of tobacco smoke. Regarding the role of health 
professionals, 73 % reported that a physician had asked them abo~t their smoking status, 
mainly in relationship to past health problems. According to patients' reports, only 30 % of 
them had physicians who encouraged them to quit. Seventy-eight percent believed that a 
physician should in principle advise to stop smoking (Table 3), yet only 4 of 88 patients would 
have expected medical support for their quit attempts. 
Table 2. Characteristics of patients at baseline (N=88) 
Characteristics 
Gender 
Age 
Origin 
men (%) 
women (%) 
mean (yrs) 
range (yrs) 
swiss (%) 
european (%) 
other (%) 
Socioeconomic status 
full time work (%) 
other (%) 
university or college degree (%) 
compulsory or secondary school (%) 
incarne> 4000 SFr. (%) 
incarne< 4000 SFr. (%) 
Age at initiation 
<age 16 (%) 
;::: age 16 (%) 
mean (yrs) 
range (yrs) 
Cigarette consumption (cig/d) 
mean 
range 
Positive aspects of smoking (%) 
relaxation in stress 
pleasure 
integration in a group 
ritual, attitude 
Number 
81 
19 
51 
19 to 81 
72 
18 
10 
49 
51 
35 
65 
67 
33 
. 23 
76 
18 
11 to 30 
26 
2 to 60 
40 
23 
21 
IO 
Table 3. Smoking cessation data (N=88 except * N=86) 
Characteristics 
Previous quit attempts 
1-2 
3-6 
no previous attempts 
Abrupt stop 
Method 
none 
nicotine substitution 
other 
Cessation difficulty 
difficult 
easy 
Social support 
none 
family/friends 
health professional 
Positive effects of cessation 
global health improvement 
symptom improvement 
Motivations to quit 
general health concern 
specific symptoms 
specific clinical signs 
right tme to stop 
Negative aspects of smoking 
general threaf to health 
risk of pulmonary disease 
nicotine addiction 
nuisance to nonsmokers 
indoor air pollution 
Social pressure 
blamed 
never blamed 
Information level 
light cigarettes Jess noxious 
yes/no opinion 
no 
nicotine addictive 
yes 
no/no opinion 
filter offers protection 
yes 
non/no opinion 
Physician attitude 
asked about smoking status 
yes 
no 
encouraged to quit 
yes 
no 
should advise to quit 
)'.eS 
no 
Percent 
64 
23 
13 
93 
83 
2 
14 
70* 
30* 
76 
22 
2 
48 
32 
39 
23 
22 
13 
55 
22 
17 
14 
13 
45 
65 
26 
74 
90 
10 
52 
48 
73 
27 
34 
66 
78 
22 
12 
13 
4. DISCUSSION 
This study has shown that the vast majority of smokers try to stop at least once or twice before 
they achieve abstinence. Smoking cessation is a dynamic process in which lessons from past, 
failures and motivations to quit are gradually integrated to enable the addicted smoker to 
escape a vicious behavioral circle. After failed attempts, a medical intervention is particularly 
useful to help to the determined quitter. In our sample, virtually all patients reported they 
stopped abruptly and without medical assistance. This perception might not reflect reality, 
since previous counseling by general practitionners might have pushed the .smoker forward in 
the sequence of the stages of change (e.g., progressing from precontemplation to 
contemplation). Furthermore, many patients quit before new therapeutic developments 
became available. Only 25 % of them reported having received community support during 
their quit attempt. Thus many of these quitters were alone to cope with withdrawal 
symptoms, weight gain and mood alterations while being constantly exposed to tobacco 
through active smokers at home, school or the workplace. This negative social situation, in 
addition to nicotine dependence, may explain why 70 % of the patients described the cessation 
process as difficult. 
On average, the patients started to · smoke at age 18. For this historical cohort who 
predominately began smoking during the 1970s, the period between adolescence and early 
adulthood was clearly the age of risk. Almost all patients were in frequent contact with active 
smokers at the time of initiation, which illustrates the influence of peer pressure in starting to 
smoke, in addition to social tolerance towards smoking. 
As observed in previous studies, the main motivation to quit appears to be mostly related to 
general or specific concerns about persona! health (19). About 10 % stopped smoking because 
the retail price of cigarettes was too high. The subjective negative aspects of smoking 
underlying the decision to quit were general or specific threat to health (such as respiratory or 
cardiovascular diseases and cancer), nicotine addiction, alteration in body odor, changes in 
indoor air quality, and nuisance to nonsmokers. This sensitive point must be emphasized. The 
smoker is often pictured as an irresponsible person who selfishly exposes nonsmokers to the 
dangers of passive smoke. Our data demonstrate that smokers are usually èoncerned about the 
impact of their habit on the health of others and this can become a major impetus to stop. This 
aspect of the smoker's psychology has been frequently omitted from prevention campaigns. 
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That 65 % of our patients reported not having been blamed for smoking by relatives or peers 
helps us to understand how implicit social tolerance of tobacco smoke acts as a positive 
reinforcing message. Furthermore, in this model, passive smoke is accepted as a respect of 
individual choices. 
Our patients were well informed about the deleterious health consequences of smoking. This 
is probably the result of over 20 years' worth of diffusion of medical knowledge through mass 
media. However, some discordance was observed on the level of information on the properties 
of specific tobacco products. Most of the patients knew that low-nicotine cigarettes are as 
dangerous as regular ones and that nicotine is addictive. But half believed the filter protects 
the user from health hazards; this belief may be due to marketing by the tobacco industry and 
the spread of misinformation. 
This study demonstrates another interesting feature of current medical practice for tobacco 
smoking. According to our patients, even if 70 % of physicians questioned them about their 
smoking status, only 30% of patients ever received cessation advice by health professionals. 
These figures paint ·a troubling picture of practitioners who seemed to address this sensitive 
problem without offering the patients the full range of available treatments. An adequate 
involvment of health professionals on this important issue could be fostered by postgraduate 
training sessions and fair compensation for preventive.care (21). 
Our study main limitations are the small sample size (N = 88) and the high percentage of 
males. The large proportion of men may represent selection bias if men were more likely to 
participate in the study than women. However, medical literature is consistent with the fact 
that female gender is a negative predictor of smoking cessation, which may account for the 
overrepresentation by males (22,23). Patients with higher educational status were 
overrepresented in our sample of successful quitters. All the other socioeconomic and 
demographic characteristics of patients in our sample correlated with those expected from the 
general medical setting (24). 
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5. CONCLUSION 
Smoking cessation is an individual choice that must follow a critical behavioral change. This 
choice arises from a gradual awareness of a negative balance between the benefits and harms 
from tobacco use. This shift in thinking is constantly challenged by a deeply anchored and 
multifaceted dependence. The 88 former smokers of this sample quitted mostly on their own, 
after one or more failed attempts, and with very little medical or social support. The 
predominant motivation to quit was concern about personal health, either general or centered 
on specific symptoms or clinical signs. This reflects the fact that patients were cognizant of 
the hazards associated with tobacco use. Most of them described this experience as very or 
rather difficult. They didn't seek medical help. 
There are two important implications of these results. First, patients were not informed of the 
recent therapeutic developments. Furthermore, health professionals were not adequately 
involved in cessation programmes and did not provide the full range of current treatment 
options. Postgraduate training sessions could encourage physician involvement in counseling 
and preventive activities. Second, the smoker is sensitive to community influence; in this 
respect, excessive social tolerance to passive smoke facilitates initiation and maintenance of 
tobacco use. As a major public health objective, abstinence $hould thus be encouraged by 
health authorities, medical professionals and community members. This social pressure 
should strive to dissuade smoking behaviour without discriminating smokers. 
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APPENDIX 1 
DSM-IV criteria (or nicotine dependence (305.10) 
A maladaptative pattern of nicotine use, leading to clinically significant impairment or 
distress, as manifested by three or more of the following, occurring at any time in the same 
12-month period: 
· 1. Tolerance as defined by either of the following: 
a. A need to markedly increased amounts of nicotine to achieve desired effect. 
b. A matkedly diminished effect with continued use of the same amount of nicotine (i.e. 
absence of nausea, dizziness and other symptoms of initial nicotine use). 
2. Withdrawal as manifested by either of the following: 
a. The characteristic withdrawal syndrome for nicotine. 
b. The same or a closely related substance is taken to relieve or avoid withdrawal 
symptoms. 
3. Nicotine is often taken in larger amounts or over a longer period than was intended. 
4. There is a persistent desire or unsuccessful effort to eut down or control substance use. 
5. A great deal of time is spent in activities necessary to obtain nicotine or recover from its 
effects. 
6. Important social, occupational, or recreational activities are given up or reduced because 
of substance use. 
7. The substance use is continued despite knowledge of having a persistant or recurrent 
physical or psychological problem that is likely to have been caused or exacerbated by the 
substance. 
8. Characteristic withdrawal symptoms. 
9. Substance often taken to relieve or avoid withdrawal symptoms. 
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APPENDIX2 
ICD-10 criteria (or dependence syndrome (FI 7.2) 
Dependence syndrome is defined by a cluster of behavioral, cognitive and physiological 
phenomena that develop after repeated use of a psychoactive substance, including at least 
three of the following: 
1. A strong or compulsive desire to take the psychoactive substance. 
2. Difficulties in controlling its use (initiation or cessation of consumption or level of use) 
3. Characteristic withdrawal syndrome (when lowering or cutting down substance use) or 
substance consumption to avoid withdrawal symptoms. 
4. Increased tolerance to substance effects (a larger amount is needed to achieve desired 
effect). 
5. Higher priority given to substance use than to other activities and interests or increase in 
time spent to obtain or consume the psychoactive substance or recover from its effects. 
6. Persistance. in substance use despite appearance of harmful consequences. 
APPENDIX3 
Fagerstrom Test {or Nicotine Dependence (FTND) 
FTND 
1. How soon after you wake up do within 5 min 
you smoke your first cigarette? 6-30 min 
· 31-60 min 
after 60 min 
2. Do you find it difficult to refrain yes 
from smoking in places where it is no 
forbidden? 
3. Which cigarette would you hate first in morning 
most to give up? any other 
4. How many cigarettes per day do <IO 
you smoke? 11-20 
21-30 
>30 
5. Do you smoke more frequently yes 
during the first hours after waking no 
than during the rest of the day? 
6. Do you smoke if you are so ill that yes 
you are in bed most of the day? no 
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